Search
01/08/2022
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data
Hemmig, AK, Gozzoli, D, Werlen, L, Ewald, H, Aschwanden, M, Blockmans, D, Brouwer, E, Buchanan, RRC, Camellino, D, Campochiaro, C, Cimmino, MA, Corominas, H, Gloy, V, Henckaerts, L, Kyburz, D, Moya-Alvarado, P, Owen, CE, Stegert, M, Tomelleri, A, van Sleen, Y, Yamashita, H, Imfeld, S, Berger, CT, Hemkens, LG, Daikeler, T. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022; 55DOI:10.1016/j.semarthrit.2022.152017. PMID:35537222. IF:5.000(Q2/3D).
01/08/2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases
Zozaya N., Arrizubieta Basterrechea M.I., Bollo E., Castellví I., Espín J., Ortego N., Poveda-Andrés J.L., Rodríguez Portal J.A., Rivero A., Marcos-Rodríguez J.A., Verde L.. A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2022; 38(1)DOI:10.1017/S0266462322000459. PMID:35912833. IF:3.200(Q2/5D).
01/08/2022
Transbronchial Cryobiopsy Bohemian Rhapsody
Torrego A., Pajares V., Maldonado F., Hetzel J.. Transbronchial Cryobiopsy Bohemian Rhapsody. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(8)DOI:10.1016/j.arbres.2021.08.004. PMID:35312593. IF:8.000(Q1/2D).
01/08/2022
How reliably can algorithms identify eosinophilic asthma phenotypes using non-invasive biomarkers?
Betancor, D, Olaguibel, JM, Rodrigo-Munoz, JM, Arismendi, E, Barranco, P, Barroso, B, Bobolea, I, Cardaba, B, Cruz, MJ, Curto, E, Del Pozo, V, Gonzalez-Barcala, FJ, Martinez-Rivera, C, Mullol, J, Munoz, X, Picado, C, Plaza, V, Quirce, S, Rial, MJ, Soto, L, Valero, A, Valverde-Monge, M, Sastre, J. How reliably can algorithms identify eosinophilic asthma phenotypes using non-invasive biomarkers?. Clinical and Translational Allergy. 2022; 12(8)DOI:10.1002/clt2.12182. PMID:36000018. IF:4.400(Q2/5D).
01/08/2022
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019
Fanciulli, C, Berenguer, J, Busca, C, Vivancos, MJ, Tellez, MJ, Dominguez, L, Domingo, P, Navarro, J, Santos, J, Iribarren, JA, Morano, L, Artero, A, Moreno, J, Rivero-Roman, A, Santos, I, Giner, L, Arminanzas, C, Montero, M, Manzardo, C, Cifuentes, C, Garcia, C, Galindo, MJ, Ferrero, OL, Sanz, J, de la Fuente, B, Rodriguez, C, Gaspar, G, Perez, L, Losa, JE, Force, L, Veloso, S, Martinez-Alfaro, E, Jarrin, I, De Miguel, M, Garcia, JG. Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019. HIV MEDICINE. 2022; 23(7)DOI:10.1111/hiv.13229. PMID:35037379. IF:3.000(Q3/7D).
01/08/2022
Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia
Casado, JA, Valeri, A, Sanchez-Dominguez, R, Vela, P, Lopez, A, Navarro, S, Alberquilla, O, Hanenberg, H, Pujol, R, Segovia, JC, Minguillon, J, Surralles, J, de Heredia, CD, Sevilla, J, Rio, P, Bueren, JA. Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia. JOURNAL OF CLINICAL INVESTIGATION. 2022; 132(15)DOI:10.1172/JCI142842. PMID:35671096. IF:15.900(Q1/1D).
01/08/2022
The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents
Atenza, CZ, Anguera, G, Melia, MR, De Lamo, LA, Sullivan, I, Joaquin, AB, Lopez, JS, Ortiz, MA, Mulet, M, Vidal, S, Majem, M. The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents. CANCER IMMUNOLOGY IMMUNOTHERAPY. 2022; 71(8)DOI:10.1007/s00262-021-03107-y. PMID:34984538. IF:5.800(Q1/3D).
01/08/2022
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia
Ramos-Muntada, M, Trincado, JL, Blanco, J, Bueno, C, Rodriguez-Cortez, VC, Bataller, A, Lopez-Millan, B, Schwab, C, Ortega, M, Velasco, P, Blanco, ML, Nomdedeu, J, Ramirez-Orellana, M, Minguela, A, Fuster, JL, Cuatrecasas, E, Camos, M, Ballerini, P, Escherich, G, Boer, J, DenBoer, M, Hernandez-Rivas, JM, Calasanz, MJ, Cazzaniga, G, Harrison, CJ, Menendez, P, Molina, O. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia. Molecular Oncology. 2022; 16(16)DOI:10.1002/1878-0261.13276. PMID:35726693. IF:6.600(Q1/3D).